Mediplantex National Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was VND 183,524.21 million compared to VND 175,950.57 million a year ago. Net income was VND 4,294.4 million compared to net loss of VND 1,568.88 million a year ago. Basic earnings per share from continuing operations was VND 395 compared to basic loss per share from continuing operations of VND 167 a year ago.